JEANATOPE
LOE Approachingalbumin iodinated i-125 serum
BLAINJECTIONINJECTABLEPriority Review
Approved
Feb 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 9h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
JEANATOPE is an iodinated serum albumin labeled with radioactive iodine-125, used as a diagnostic imaging agent for nuclear medicine studies. This radiopharmaceutical enables visualization of blood volume, cardiac output, and vascular integrity through radionuclide imaging. It functions as a tracer compound that allows clinicians to assess circulatory dynamics and tissue perfusion non-invasively.
LOE Approaching
With LOE approaching and minimal linked job activity, the JEANATOPE franchise is likely in maintenance or wind-down mode with small, specialized teams.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on JEANATOPE offers limited career growth given zero linked job openings and mature product lifecycle. This role suits professionals managing legacy portfolios or regulatory wind-down rather than those seeking dynamic commercial or clinical advancement.
Regulatory SpecialistMedical Science Liaison (Imaging)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.